Hunter syndrome is a rare genetic disorder characterized by the deficiency or absence of an enzyme called iduronate-2-sulfatase. This leads to the buildup of certain substances in the body, causing progressive damage to various organs and tissues. The ICD-10 code for Hunter syndrome is E76.2, while the ICD-9 code is 277.5. These codes are used for medical classification and billing purposes.
Hunter syndrome, also known as mucopolysaccharidosis type II (MPS II), is a rare genetic disorder that falls under the category of lysosomal storage diseases. It is caused by a deficiency of the enzyme iduronate-2-sulfatase, leading to the accumulation of glycosaminoglycans in various tissues and organs. The International Classification of Diseases, Tenth Revision (ICD-10) provides a specific code for Hunter syndrome, which is E76.2. This code allows for accurate identification and classification of the disorder in medical records and billing systems.
In contrast, the International Classification of Diseases, Ninth Revision (ICD-9) had a different coding system. The corresponding code for Hunter syndrome in ICD-9 was 277.5. However, it is important to note that ICD-9 has been replaced by ICD-10, which provides a more comprehensive and detailed classification system for medical conditions.
The specific ICD-10 code for Hunter syndrome (E76.2) facilitates effective communication among healthcare professionals, researchers, and insurers. It allows for accurate tracking of the prevalence and incidence of the disorder, leading to improved understanding and management of Hunter syndrome. By utilizing the appropriate ICD-10 code, healthcare providers can ensure proper documentation and coding, which is crucial for efficient healthcare delivery and reimbursement processes.